Aucun résultat
Dr. April Rose is a clinician scientist in the Department of Oncology at McGill University, and an Attending Medical Oncologist at the Jewish General Hospital (JGH), where she manages patients with melanoma, bladder and prostate cancers. Dr. Rose has an interest in clinical drug development and is a Principal Investigator on several Phase I/II/III clinical trials for patients with metastatic cancers run through the Clinical Research Unit (CRU) and Clinical Research Program (CRP) at the JGH.
Dr. Rose is a FRQS Clinical Research Scholar. Her translational-oncology research program focuses on interrogating the molecular determinants of therapeutic response and resistance for novel targeted therapies and immunotherapies in advanced cancer. She has specific interests in therapeutic targeting of proteins within the mitogen activated protein kinase (MAPK) pathway, and in advancing precision therapies for metastatic prostate cancer. Her research is funded by grants from the Canadian Institutes of Health Research (CIHR), the Canadian Cancer Society (CCS), the Cancer Research Society (CRS), and the Marathon of Hope Cancer Centers Network (MOHCCN).
A. N. Rose*‡, J. Maxwell*, E. Rousselle*, C. L. Mukonoweshuro, I. E. Elkholi, M. Riaud, M. Biondini, E. Cianfarano, I. Soria-Bretones, C. Tobin, M. McGuire, R.W.Y. Law, A. J. Elia, B. X. Wang, I. King, T. Zhang, T. Pugh, Z. Saeed Kamil, M. O. Butler, F. A. Shepherd, N. Leighl, A. Abdul Razak, A. Hansen, S. Saibil, P. L. Bedard, P. M. Siegel, L. L. Siu, D. W. Cescon, A. Spreafico‡. *Equal Contribution ‡Co-Corresponding Authors. (2025) Nature Communications. Accepted, In Press.
Virtanen, E. Kwan, K. Parekh, J. Bacon, C. F. Huang, I. P. L. Yu, L. Ryyppö, C. Bernales, G. Donnellan, C. Tam, J. Sipola, J. Nikkola, G. Vandekerkhove, S. H. Tolmeijer, K. Kukkonen, Adelia3, B. Eigl, D. Finch, R. Gagnon, Y. Hamid, E. Hardy, D. Khalaf, C. Kollmannsberger, J. Lavoie, C. Maurice-Dror, S. Miller, L. Nappi, K. Noonan, S. Parimi, A. Riminchan, E. Sartori-Mueller, M. Soleimani, J. Vergidis, M. Zulfiqar, A. Hansen, S. Hotte, M. Jafri, M. Kolinsky, S. Mukherjee, M. Ong, A. A. N. Rose, W. Tu, E. Winquist, A. Bergman, K. van der Zande , W. Zwart, N. Mehra, N. van Erp, J. Zhao, D. Rathkopf, C. Barbieri, D. Quigley, M. Nykter, N. Lack, K. N. Chi, M. Annala, A.Wyatt. (2025) Annals of Oncology.
Labidi, B. Jiao, S. Tam, P. Fallah, A. Salehi, R. Rajan, M. Alameldine, F. Brimo, W. Foulkes, A. Papadakis, N. Kaul, A. Spatz, C. Ferrario, R. R. Saleh, A. A. N. Rose‡. Cancers 2025, 17(21), 3427.
Dankner, E. Rousselle, S. Petrecca, F. Fabi, A. Nowakowski, A. Lazaratos, C. V. Rajadurai, A. Stein, D. Bian, P. Tai, A. Belaiche, M. Li, A. Quaiattini, N. Normanno, M. Arcila, A. Elkrief, D. B. Johnson, M. Ladanyi, A. A. N. Rose‡. (2025) JCO Precision Oncology 9, e2400199 (2025).
Riaud, J. Maxwell, I. Soria-Bretones, M. Dankner, M. Li, A. A. N. Rose‡. (2024) Nature Reviews Cancer. 24:105-122.
You have the power to make a difference! Your gift will support vital research at the Lady Davis Institute for Medical Research (LDI) that will translate into disease prevention, improved diagnoses, earlier detection, new and enhanced therapies, a better quality of life, wellness and hope for all of us.
Faire la différence, vous avez ce don! Votre contribution soutiendra la recherche essentielle menée à l’Institut Lady Davis qui permettra la prévention des maladies, des diagnostics plus précis, des dépistages plus rapides, des traitements innovants et plus performants, une meilleure qualité de vie, le bien-être et l’espoir pour nous tous.
Copyright © 2024 | Lady Davis Institute for Medical Research/Jewish General Hospital
Conception et développement : Yankee Media
